Skip to content
‹ Back to IndustriesHealthcare

Versatile Comfort: Transmotion TMM3 Stretcher Chair for Radiology and Speech Pathology

Key Points:  Versatility: Customizable configurations and rotating seat for lateral positioning. Comfort: Luxurious memory-foam cushioning and extending footrest for patient ease. Safety: Manual quick-release back, head/leg/torso belts, and optimal mobility with brake and steer castor system. Summary: Introducing the Transmotion TMM3 Stretcher Chair, the ultimate solution for Radiology and Speech Pathology needs. Designed with…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

·
Share

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

Key Points: 

  • Versatility: Customizable configurations and rotating seat for lateral positioning.
  • Comfort: Luxurious memory-foam cushioning and extending footrest for patient ease.
  • Safety: Manual quick-release back, head/leg/torso belts, and optimal mobility with brake and steer castor system.

Summary:

Introducing the Transmotion TMM3 Stretcher Chair, the ultimate solution for Radiology and Speech Pathology needs. Designed with patient safety, comfort, and convenience in mind, the TMM3 offers versatility and user-friendliness. Its modular design allows for custom configurations and precise positioning to meet your specific requirements, while also supporting the “one patient, one surface” commitment to increase patient throughput and reduce staff injuries.

The TMM3’s key feature is its rotating seat, allowing patients to remain seated in lateral positions without the need for uncomfortable transfers, making it ideal for modified barium swallow studies and more. Its convenient maneuverability for caregivers, including a brake and steer castor system, swing and tuck siderails, fold-down push handles, 30-inch column base, and wired hand pendant, ensures optimal mobility while maintaining patient security.

With manual quick-release back and radiolucent back for easy positioning, as well as head, leg, and torso belts for added patient safety, the TMM3 prioritizes both comfort and security. With a maximum weight limit of 350 pounds and a width of 24 inches (30.5 inches with rails extended) to accommodate a variety of patients, the TMM3 offers practicality and safety in one package.

The TMM3’s sleek and modern design seamlessly fits into any medical environment, and its durable construction ensures long-lasting use. Luxurious memory-foam cushioning and an extending footrest provide an efficient and comfortable experience for patients with radiology and speech pathology needs.

In conclusion, the Transmotion TMM3 Stretcher Chair is a versatile, user-friendly, and safe solution for Radiology and Speech Pathology needs. Its rotating seat, convenient maneuverability, and patient-focused features make it the preferred choice for healthcare professionals. With its practicality, comfort, and safety, the TMM3 is the ultimate stretcher chair for a seamless and efficient patient experience.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Book DemoSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Healthcare Insights

LeanTaaS buys LookDeep Health and brings computer vision into hospital patient rooms

LeanTaaS buys LookDeep Health and brings computer vision into hospital patient rooms

LeanTaaS said on November 3 it acquired LookDeep Health, a computer vision company, and introduced iQueue for Virtual Care, its first product built on what it calls ambient intelligence. Terms were not disclosed. The product bundles Virtual Observation, Virtual Nursing and Virtual Medicine, and LeanTaaS says hospitals can build on compatible cameras and in-room devices already installed or deploy supported hardware. The company cited reported results from LookDeep deployments, including fall-rate reductions of more than 70%, and said LookDeep's technology was evaluated in peer-reviewed research published in Frontiers in Imaging.

  • 01LeanTaaS acquired LookDeep Health and launched iQueue for Virtual Care, combining Virtual Observation, Virtual Nursing and Virtual Medicine; acquisition terms were not disclosed.
  • 02Hospitals can build on compatible cameras and in-room devices already in place or deploy supported hardware, according to LeanTaaS, which did not name camera vendors.
  • 03LeanTaaS reported results from LookDeep deployments including fall-rate reductions of more than 70% and twice as much nursing contact, figures that are the company's own and not tied to named health systems.

Nov 3, 2026

Philips posts 8% order intake growth in Q3 and books a EUR 288 million Respironics provision

Philips posts 8% order intake growth in Q3 and books a EUR 288 million Respironics provision

Royal Philips reported 8% comparable order intake growth for the third quarter of 2026, driven by Diagnosis & Treatment, with comparable sales up 3% to EUR 4.4 billion and an adjusted EBITA margin of 13.0%, up 70 basis points. The company reiterated its 2026 outlook for 3% to 4.5% comparable sales growth. Philips Respironics reached an agreement in principle with the US Department of Justice to resolve previously disclosed investigations related to its recall, and Philips recorded a EUR 288 million provision in the quarter, with payment expected in the first quarter of 2027 subject to final documentation.

  • 01Comparable order intake grew 8%, matching a year earlier, with Diagnosis & Treatment the driver; the equipment order book stands at about 40% of revenue.
  • 02Comparable sales rose 3% to EUR 4.4 billion, adjusted EBITA margin reached 13.0%, and free cash flow was EUR 384 million; the 2026 outlook was reiterated.
  • 03Philips Respironics reached an agreement in principle with the DOJ on previously disclosed recall investigations, and Philips recorded a EUR 288 million provision; the settlement is subject to final documentation.

Nov 3, 2026

Rockwell Medical agrees to buy most of Vantive's hemodialysis business for $125 million

Rockwell Medical agrees to buy most of Vantive's hemodialysis business for $125 million

Rockwell Medical agreed to acquire most of Vantive's hemodialysis business for $125 million in base consideration, plus up to $45 million in contingent payments, with closing expected mid-2027. The deal includes hemodialysis concentrates, machines, water treatment systems, and Vantive's Medolla, Italy manufacturing facility; the combined business could generate $400-450 million annually, depending on various factors.

  • 01Rockwell Medical agreed to acquire Vantive's hemodialysis concentrates, AK 98 machines, water treatment systems, and the one-million-square-foot Medolla, Italy manufacturing campus for $125 million base plus up to $45 million tied to revenue and EBITDA milestones.
  • 02Rockwell said the combined business could generate $400-450 million in annual revenue, depending on operating performance, exchange rates, market conditions and integration.
  • 03Vantive's dialyzer portfolio, including Theranova dialyzer for expanded hemodialysis, remains with Vantive; the company will focus on home dialysis and critical care after divestiture.

Nov 3, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512